DE2338787A1 - Biologisch wirksame verbindungen und zubereitungen - Google Patents

Biologisch wirksame verbindungen und zubereitungen

Info

Publication number
DE2338787A1
DE2338787A1 DE19732338787 DE2338787A DE2338787A1 DE 2338787 A1 DE2338787 A1 DE 2338787A1 DE 19732338787 DE19732338787 DE 19732338787 DE 2338787 A DE2338787 A DE 2338787A DE 2338787 A1 DE2338787 A1 DE 2338787A1
Authority
DE
Germany
Prior art keywords
compound
formula
salt
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19732338787
Other languages
German (de)
English (en)
Inventor
Geb Loan Irene Stirling
Hamish Christopher Swan P Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2338787A1 publication Critical patent/DE2338787A1/de
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C207/00Compounds containing nitroso groups bound to a carbon skeleton
    • C07C207/04Compounds containing nitroso groups bound to a carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19732338787 1972-08-01 1973-07-31 Biologisch wirksame verbindungen und zubereitungen Ceased DE2338787A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3581472A GB1454165A (en) 1972-08-01 1972-08-01 Biologically active compounds and compositions

Publications (1)

Publication Number Publication Date
DE2338787A1 true DE2338787A1 (de) 1974-02-14

Family

ID=10381816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732338787 Ceased DE2338787A1 (de) 1972-08-01 1973-07-31 Biologisch wirksame verbindungen und zubereitungen

Country Status (16)

Country Link
US (1) US3963719A (US06174465-20010116-C00003.png)
JP (1) JPS4955692A (US06174465-20010116-C00003.png)
BE (1) BE803090A (US06174465-20010116-C00003.png)
CA (1) CA1019736A (US06174465-20010116-C00003.png)
CH (1) CH609985A5 (US06174465-20010116-C00003.png)
DE (1) DE2338787A1 (US06174465-20010116-C00003.png)
DK (1) DK138019B (US06174465-20010116-C00003.png)
ES (2) ES417415A1 (US06174465-20010116-C00003.png)
FI (1) FI55662C (US06174465-20010116-C00003.png)
FR (1) FR2194438B1 (US06174465-20010116-C00003.png)
GB (1) GB1454165A (US06174465-20010116-C00003.png)
HU (1) HU171199B (US06174465-20010116-C00003.png)
IL (1) IL42858A (US06174465-20010116-C00003.png)
NL (1) NL7310579A (US06174465-20010116-C00003.png)
SE (1) SE407576B (US06174465-20010116-C00003.png)
ZA (1) ZA735210B (US06174465-20010116-C00003.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196533A (en) * 1983-04-11 1993-03-23 South Alabama Medical Science Foundation, Usa Cyclization of 5 amino-pyrimidines to quinoid 6,6 disubstituted dihydropteridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635978A (en) * 1969-01-28 1972-01-18 Univ Strathclyde Amino pyrimidines
GB1363064A (en) * 1970-07-27 1974-08-14 Wellcome Found Pyrimidine derivatives as intermediates in the synthesis of pteridines
BE787236A (fr) * 1971-08-05 1973-02-05 Wellcome Found Compositions de potentialisation

Also Published As

Publication number Publication date
NL7310579A (US06174465-20010116-C00003.png) 1974-02-05
FR2194438B1 (US06174465-20010116-C00003.png) 1976-07-02
ZA735210B (en) 1975-03-26
US3963719A (en) 1976-06-15
HU171199B (hu) 1977-11-28
CA1019736A (en) 1977-10-25
DK138019B (da) 1978-06-26
DK138019C (US06174465-20010116-C00003.png) 1978-11-13
GB1454165A (en) 1976-10-27
IL42858A0 (en) 1973-10-25
SE407576B (sv) 1979-04-02
BE803090A (fr) 1974-01-31
CH609985A5 (US06174465-20010116-C00003.png) 1979-03-30
ES417415A1 (es) 1976-06-16
FR2194438A1 (US06174465-20010116-C00003.png) 1974-03-01
ES442673A1 (es) 1977-04-16
JPS4955692A (US06174465-20010116-C00003.png) 1974-05-30
AU5873273A (en) 1975-02-06
IL42858A (en) 1977-02-28
FI55662B (fi) 1979-05-31
FI55662C (fi) 1979-09-10

Similar Documents

Publication Publication Date Title
DE60316013T2 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
DE69304076T2 (de) N-cyano-n'-pyridylguanidine als serotoninantagonisten
DE69531956T2 (de) Imidazol derivate mit proteinkinase, insbesondere egf-r tyrosinkinase, inhibierender wirkung
EP0231888B1 (de) Substituierte 2,4-Diamino-5-benzylpyrimidine, deren Herstellung und deren Verwendung als Arzneimittel mit antimikrobieller Wirksamkeit
EP0760664A1 (de) Verwendung von pteridin-derivaten als hemmstoffe der no-synthase
DD275048A5 (de) Verfahren zur herstellung von isoflavanen
CH630881A5 (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine.
DE69731940T2 (de) Uracilderivate enthaltende krebsmetastasen inhibitoren
EP1882476B1 (de) Herstellung von antimikrobiellen Formulierungen unter Verwendung von 7-Oxa-2-thia 1,5-diazabicyclo[3.3.1]nonan-2,2-dion
DE60209806T2 (de) 2-amino-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
DE3855520T2 (de) Methode zur Verbesserung des Schlafes
DE3613447C2 (US06174465-20010116-C00003.png)
DE2238536C2 (de) Zubereitungen zur Behandlung von Mikrobeninfektionen
DE3035688C2 (US06174465-20010116-C00003.png)
AT392469B (de) Verfahren zur herstellung von neuen chinolinderivaten
DE2814202C2 (de) Verwendung von Uracilderivaten zur Bekämpfung von Krebs oder krebsartigen Erkrankungen
DE2338787A1 (de) Biologisch wirksame verbindungen und zubereitungen
US4073786A (en) 2-Amino-4-hydroxy-6-hydroxymethyl-7,7-diethyl-7,8-dihydropteridine and the 7-spirocyclohexyl analogue thereof
DE2338788A1 (de) Pteridinderivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
US4795639A (en) Potentiating formulations
DE2634358B2 (de) 2,4-Diamino-5-(3,5-dihalogen-4aminobenzyD-pyrimidine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
EP0196330B1 (de) Verwendung von pyrrothinderivaten
DE2404594A1 (de) Biologisch wirksame verbindungen und zubereitungen und verfahren zu ihrer herstellung
DE1910283A1 (de) Arzneimittel mit einem Gehalt an (3,5,3',5'-Tetraoxo)-1,2-dipiperazinoalkanverbindungen und Verfahren zur Herstellung der Verbindungen
US4036961A (en) Pharmaceutical compositions containing pteridines

Legal Events

Date Code Title Description
OD Request for examination
8131 Rejection